[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335106-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-335106-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","recent-development-of-fluoroquinolone-derivatives-as-anticancer-agents","Recent Development of Fluoroquinolone Derivatives as Anticancer Agents","","Cancer is the second leading cause of death worldwide after cardiovascular disease, and treatment relies on pharmacotherapy, radiotherapy, and surgical tumor removal. High costs and complexity in designing and marketing new drugs motivate strategies such as drug repositioning. Fluoroquinolones, broad-spectrum synthetic antibiotics, are also investigated for antiproliferative actions in highly lethal cancers. The review summarizes recent progress in fluoroquinolone derivative development with anticancer and cytotoxic potential, including structure–activity relationships and future research directions.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/recent-development-of-fluoroquinolone-derivatives-as-anticancer-agents/335106/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/recent-development-of-fluoroquinolone-derivatives-as-anticancer-agents/335106.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"Why is new anticancer drug development challenging, and what alternative approach is discussed?","Question",{"text":62,"@type":63},"Designing, synthesising, and marketing new anticancer substances involves high costs. Drug repositioning is presented as an attractive solution to reduce these barriers.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What are fluoroquinolones and why are they relevant to cancer research?",{"text":67,"@type":63},"Fluoroquinolones are synthetic antibiotics with broad-spectrum antibacterial activity. They are also reported to show antiproliferative effects on cells of the most lethal cancers.",{"name":69,"@type":60,"acceptedAnswer":70},"What does the review focus on regarding fluoroquinolone derivatives?",{"text":71,"@type":63},"It presents current progress in developing new fluoroquinolone derivatives with potential anticancer and cytotoxic activity, including structure–activity relationships and possible directions for further development.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},335106,1790928621,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","molecules   \nReview  \nRecent Development of Fluoroquinolone Derivatives as Anticancer Agents  \nJustyna Nowakowska 1,*, Dominika Radomska 2, Robert Czarnomysy 2 and Krzysztof Marciniec 1, *  \nCitation: Nowakowska, J.; Radomska, D.; Czarnomysy, R.; Marciniec, K. Recent Development of Fluoroquinolone Derivatives as Anticancer Agents. Molecules 2024, 29, 3538. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)molecules29153538  \nAcademic Editor: Richard A. Bunce  \nReceived: 20 June 2024  \nRevised: 17 July 2024  \nAccepted: 25 July 2024  \nPublished: 27 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Organic Chemistry, Medical University of Silesia, Jagiellonska 4, 41-200 Sosnowiec, Poland  \n2 Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland; [dominika.radomska@umb.edu.pl](dominika.radomska@umb.edu.pl) (D.R.); [robert.czarnomysy@umb.edu.pl](robert.czarnomysy@umb.edu.pl) (R.C.)  \n* Correspondence: [s85039@365.sum.edu.pl](s85039@365.sum.edu.pl) (J.N.); [kmarciniec@sum.edu.pl](kmarciniec@sum.edu.pl) (K.M.)  \nAbstract: Cancer is the second leading cause of death in the world following cardiovascular disease. Its treatment, including radiation therapy and surgical removal of the tumour, is based on pharmacotherapy, which prompts a constant search for new and more effective drugs. There are high costs associated with designing, synthesising, and marketing new substances. Drug repositioning is an attractive solution. Fluoroquinolones make up a group of synthetic antibiotics with a broad spectrum of activity in bacterial diseases. Moreover, those compounds are of particular interest to researchers as a result of reports of their antiproliferative effects on the cells of the most lethal cancers. This article presents the current progress in the development of new fluoroquinolone derivatives with potential anticancer and cytotoxic activity, as well as structure–activity relationships, along with possible directions for further development.  \nKeywords: fluoroquinolones; anticancer; cytotoxic activity; metal ion complexes  \n1. Introduction  \nThe National Cancer Institute (NCI) defines cancer as a disease in which some of the body’s cells grow uncontrollably and spread throughout the body. Long periods of cell division, accumulation of oncogenic mutations, and favourable localisation of lesions allowing for the accumulation of abnormal cells appear to be necessary to initiate the carcinogenesis process [1] . According to statistical data, cancer is the second leading cause of death in the world following cardiovascular disease [2–4] . Among the most lethal cancers, the World Health Organisation indicates lung, colon, liver, stomach, and breast cancers [5] . Cancer treatment is based on a reductionist approach. The methods used primarily encompass pharmacotherapy (chemotherapy, immunotherapy), radiotherapy, and surgical removal of the lesion [6] . Despite medical progress, the prognosis for patients may remain unfavourable. The lack of a perfect panacea and the high costs of designing, synthesising, and marketing new medicinal substances encourage the search for an anticancer drug among derivatives of available drugs through the so-called repositioning of the drug [7] .  \nFluoroquinolones make up a group of synthetic antibacterial drugs with a broad spectrum of activity in invasive medical and veterinary infections. They are used in infections of the urogenital tract, respiratory tract, and gastrointestinal tract caused by Gram-positive and Gram-negative microorganisms [8] . They are also successfully used in th","cbCaiczdtWwbWQXY","https://ap.wps.com/l/cbCaiczdtWwbWQXY","pdf",8473642,22,"English","# Introduction\n## Cancer background and current treatment approaches\n## Rationale for drug repositioning\n## Overview of fluoroquinolones and their pharmacology\n# Development of fluoroquinolone derivatives","[{\"question\":\"Why is new anticancer drug development challenging, and what alternative approach is discussed?\",\"answer\":\"Designing, synthesising, and marketing new anticancer substances involves high costs. Drug repositioning is presented as an attractive solution to reduce these barriers.\"},{\"question\":\"What are fluoroquinolones and why are they relevant to cancer research?\",\"answer\":\"Fluoroquinolones are synthetic antibiotics with broad-spectrum antibacterial activity. They are also reported to show antiproliferative effects on cells of the most lethal cancers.\"},{\"question\":\"What does the review focus on regarding fluoroquinolone derivatives?\",\"answer\":\"It presents current progress in developing new fluoroquinolone derivatives with potential anticancer and cytotoxic activity, including structure–activity relationships and possible directions for further development.\"}]","Recent Development of Fluoroquinolone Derivatives as Anticancer Agents | PDF",1790009683,55]